Gilead Sciences, Inc.
CH ˙ SWX ˙ US3755581036
SecurityCH:GILD / Gilead Sciences, Inc.
InstitutionFirst City Capital Management, Inc.
Latest Disclosed Ownership2,175 shares
Latest Disclosed Value $ 303,130
First City Capital Management, Inc. ownership in GILD / Gilead Sciences, Inc.

On April 17, 2026 - First City Capital Management, Inc. filed a 13F-HR form disclosing ownership of 2,175 shares of Gilead Sciences, Inc. (CH:GILD) valued at $303,130 USD as of March 31, 2026. The entity filed a previous 13F-HR on January 14, 2026 disclosing 2,175 shares of Gilead Sciences, Inc.. This represents a change in shares of 0.00% during the quarter.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date		 Effective
Date		Form Security Class ID Avg Price
Paid (Est)		 Reported
Shares		 ΔShares ΔShares
(%)		 Reported
Value
(x1000)		 ΔValue
(%)		 Alloc
(%)		 ΔAlloc ΔAlloc (%) Cost Basis
(x1000)		 Unrealized
Gain/Loss
(x1000)
2026-04-17 2026-03-31 13F GILEAD SCIENCES COM 375558103 2,175 0 0.00 303 13.91 0.1607
2026-01-14 2025-12-31 13F GILEAD SCIENCES COM 375558103 2,175 -100 -4.40 267 5.56 0.1410
2025-10-21 2025-09-30 13F GILEAD SCIENCES COM 375558103 2,275 -21 -0.91 253 -0.79 0.1362
2025-07-15 2025-06-30 13F GILEAD SCIENCES COM 375558103 2,296 0 0.00 255 -1.17 0.1470
2025-04-11 2025-03-31 13F GILEAD SCIENCES COM 375558103 2,296 5 0.22 257 21.80 0.1542
2025-01-03 2024-12-31 13F GILEAD SCIENCES COM 375558103 2,291 2,291 212 0.1126
2023-07-19 2023-06-30 13F GILEAD SCIENCES COM 375558103 0 -2,477 -100.00 0 -100.00
2023-05-01 2023-03-31 13F GILEAD SCIENCES COM 375558103 2,477 -32 -1.28 204 -5.58 0.1191
2023-02-13 2022-12-31 13F GILEAD SCIENCES COM 375558103 2,509 2,509 215 0.1297
2022-02-07 2021-12-31 13F GILEAD SCIENCES COM 375558103 0 -3,027 -100.00 0 -100.00
2021-10-28 2021-09-30 13F GILEAD SCIENCES COM 375558103 3,027 -200 -6.20 211 -7.86 0.1188
2021-08-13 2021-06-30 13F GILEAD SCIENCES COM 375558103 3,227 0 0.00 229 5.05 0.1259
2021-05-13 2021-03-31 13F GILEAD SCIENCES COM 375558103 3,227 3,227 218 0.1263
2021-02-12 2020-12-31 13F GILEAD SCIENCES COM 375558103 0 -5,446 -100.00 0 -100.00
2020-11-16 2020-09-30 13F GILEAD SCIENCES COM 375558103 5,446 1,902 53.67 349 27.84 0.1296
2020-08-14 2020-06-30 13F GILEAD SCIENCES COM 375558103 3,544 350 10.96 273 14.23 0.2096
2020-05-15 2020-03-31 13F Gilead Sciences CS 375558103 3,194 -300 -8.59 239 5.29 0.2342
2020-02-10 2019-12-31 13F Gilead Sciences CS 375558103 3,494 -1,733 -33.15 227 -31.42 0.1562
2019-11-13 2019-09-30 13F Gilead Sciences CS 375558103 5,227 -1,500 -22.30 331 -27.09 0.2421
2019-08-14 2019-06-30 13F Gilead Sciences CS 375558103 6,727 100 1.51 454 5.34 0.3308
2019-05-13 2019-03-31 13F Gilead Sciences CS 375558103 6,627 -1,550 -18.96 431 -15.66 0.3098
2019-02-13 2018-12-31 13F Gilead Sciences CS 375558103 8,177 -2,450 -23.05 511 -37.76 0.3983
2018-11-14 2018-09-30 13F Gilead Sciences CS 375558103 10,627 1,100 11.55 821 21.63 0.5459
2018-08-13 2018-06-30 13F Gilead Sciences CS 375558103 9,527 -100 -1.04 675 -7.02 0.4828
2018-05-15 2018-03-31 13F Gilead Sciences CS 375558103 9,627 0 0.00 726 5.22 0.5432
2018-02-12 2017-12-31 13F Gilead Sciences CS 375558103 9,627 -1,050 -9.83 690 -20.23 0.4706
2017-10-31 2017-09-30 13F Gilead Sciences CS 375558103 10,677 -150 -1.39 865 12.92 0.6049
2017-08-14 2017-06-30 13F Gilead Sciences CS 375558103 10,827 -155 -1.41 766 2.68 0.5556
2017-05-17 2017-03-31 13F/A-1 Gilead Sciences CS 375558903 10,982 52 0.48 746 -4.73 0.5495
2017-05-15 2017-03-31 13F Gilead Sciences CS 375558903 3,227 269
2017-02-13 2016-12-31 13F Gilead Sciences CS 375558903 10,930 10,930 0.00 783 0.5880
2016-02-12 2015-12-31 13F Gilead Sciences CS 375558103 0 -3,395 -100.00 0 -100.00
2015-11-16 2015-09-30 13F Gilead Sciences CS 375558103 3,395 3,395 0.00 333 0.2450
2015-08-17 2015-06-30 13F Gilead Sciences CS 375558103 0 -2,745 -100.00 0 -100.00
2015-05-07 2015-03-31 13F Gilead Sciences CS 375558103 2,745 70 2.62 269 6.75 0.1863
2015-02-13 2014-12-31 13F Gilead Sciences CS 375558103 2,675 0 0.00 252 -11.27 0.1740
2014-11-13 2014-09-30 13F Gilead Sciences CS 375558103 2,675 -300 -10.08 285 15.45 0.2041
2014-08-18 2014-06-30 13F Gilead Sciences CS 375558103 2,975 0 0.00 247 10.31 0.1753
2014-02-14 2013-12-31 13F Gilead Sciences CS 375558103 2,975 2,975 223 0.1830
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.